Publication Date: May-2012
Format: PDF
Pages: 164
Publisher: MarketsandMarkets
Table of Contents

Anesthesia is a condition in which sensation is totally or partially blocked. This enables the patients to undergo medical procedures and surgery. Based on the applications (type of surgery or medical procedure) anesthetic drugs are broadly categorized into two types; i.e. local anesthetic drugs and general anesthetic drugs. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation.

The anesthesia drugs market research report specially focuses on ketamine market in U.S.A. Under general anesthesia drugs category, drugs such as propofol, midazolam & diazepam, fospropofol disodium, sodium pentothal, ketamine, methohexital sodium, pentobarbital, etomidate and fentanyl are studied. The U.S. general anesthesia market was valued at $2 billion in 2011 and is poised to grow at a CAGR of approximately 4% to reach $2.3 billion by 2015.
find out more

Publication Date: 15-May-2012
Format: PDF
Pages: 134
Publisher: Global Markets Direct


Global Market Direct’s pharmaceuticals report, “Dr. Reddy's Laboratories Limited - Product Pipeline Review - 2012” provides data on the Dr. Reddy's Laboratories Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Dr. Reddy's Laboratories Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Dr. Reddy's Laboratories Limited and industry-specific third party sources, put together by Global Markets Direct’s team.
find out more

Publication Date: 15-May-2012
Format: PDF
Pages: 621
Publisher: Global Markets Direct


Global Market Direct’s pharmaceuticals report, “Eli Lilly and Company - Product Pipeline Review - 2012” provides data on the Eli Lilly and Company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Eli Lilly and Company’s corporate website, SEC filings, investor presentations and featured press releases, both from Eli Lilly and Company and industry-specific third party sources, put together by Global Markets Direct’s team.
find out more